✦ LIBER ✦

A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer

✍ Scribed by Michael V Seiden; Franco Muggia; Allan Astrow; Ursula Matulonis; Susanna Campos; Maria Roche; Julia Sivret; Jason Rusk; Emma Barrett

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-789 Phase II study of OSI-211 (liposom

✍ Ranson, M.; Dobbs, T.; Modiano, M.; Nicolson, M.; Fyfe, D.; Harper, P.; Sandler, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Phase II study of the combination of peg

✍ M. VERHAAR-LANGEREIS; A. KARAKUS; M. Van EIJKEREN; E. VOEST; E. WIT 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Phase II study of bevacizumab with lipos

✍ Verschraegen, C. F.; Czok, S.; Muller, C. Y.; Boyd, L.; Lee, S. J.; Rutledge, T. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 144 KB

Phase II study of OSI-211 (liposomal lur

✍ F. Duffaud; M. Borner; P. Chollet; J.B. Vermorken; J. Bloch; M. Degardin; F. Rol 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 248 KB

Phase II study of weekly topotecan in pa

✍ Tally Levy; Moshe Inbar; Joseph Menczer; Dan Grisaru; Marek Glezerman; Tamar Saf 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 140 KB

A phase II study of sequential carboplat

✍ Guppy, A E; Nelstrop, A E; Foster, T; Agarwal, R; Seckl, M J; Rustin, G J S 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB